Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity
Lindvi Gudmundsdotter*, Charlotta Nilsson, Andreas Brave, Bo Hejdeman, Patricia Earl, Bernard Moss, Merlin Robb, Josephine Cox, Nelson Michael, Mary Marovich, Gunnel Biberfeld, Eric Sandström, Britta Wahren
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
62Scopus
citations
Fingerprint
Dive into the research topics of 'Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity'. Together they form a unique fingerprint.